We are entering a new era of patient treatment options thanks to cutting-edge technologies that are changing the way life science companies approach and execute pharmaceutical research. One of the more significant solutions that support the faster and more efficient development of new pharmaceutical products – such as the COVID-19 vaccine, which was developed faster than any other vaccine in history – is artificial intelligence (AI)-driven data analysis. Thanks to modern life science technology
Read More
Artificial Intelligence in Healthcare | News, Analysis, Insights - HIT Consultant
EchoNous Alliance with Samsung for AI-Guided Ultrasound
What You Should Know:
- EchoNous, a company delivering AI-enabled handheld ultrasound capable of producing diagnostic-quality images, forms an alliance with Samsung that enables its Point-of-Care Ultrasound (POCUS) Kosmos platform run on Samsung’s Galaxy Tab Pro tablets (models 12.0 and higher).
- Made possible through the EchoNous/Samsung alliance, this new compatibility will lower the overall price point of the Kosmos platform, which already costs tens of thousands of dollars less than
Read More
Connected Devices Selection: Considerations for A Digital-First Approach to Data Collection
In recent years, digital health technologies (DHTs) have significantly changed the way we collect data within clinical trials. This is partially due to the overarching industry shift toward patient-centricity, but in some cases, it is also due to the commercial availability of powerful technology solutions not previously feasible for use in medical devices. In the past, nearly all patient data have traditionally been acquired by purpose-built machines manufactured by relatively small-scale
Read More
Avenda Health Receives FDA Exemption for AI-Enabled Prostate Cancer Therapy
What You Should Know:
- Avenda Health, an AI healthcare company creating the future of prostate cancer care, has received FDA Investigational Device Exemption (IDE) for its FocalPoint ablation system. The IDE will allow the technology, powered by iQuest, to be used in a randomized control trial to show superiority over the standard of care for the treatment of prostate cancer.
- FocalPoint is Avenda Health’s focal laser ablation system designed to treat localized prostate cancer
Read More
Ellipsis Health & Ceras Health Integrate to Bring Human Voice as a Biomarker for Mental Health
What You Should Know:
- Ellipsis Health and Ceras Health today announced a partnership that will integrate Ellipsis Health's breakthrough technology that uses the human voice as a biomarker for mental health and wellbeing into Ceras' clinical monitoring platform.
- This integration will combine Ellipsis Health's AI and deep learning technology with Ceras Health's clinical monitoring and health data analytics platform, enabling real-time severity scores for anxiety and depression to improve
Read More
FundamentalVR Raises $20M for VR Surgical Simulation Platform
What You Should Know:
- FundamentalVR has raised an additional $20M to significantly accelerate medical skill-transfer and increase surgical proficiency through its world-leading medical simulation platform, Fundamental Surgery.
- The funding was led by EQT Life Sciences investing from the LSP Health Economics Fund 2 and joined by prior investors Downing Ventures. The new investments follow a Series A round in October 2019 and bring the
Read More
H1 Launches AI-Powered and Evidence-Based Interactions
What You Should Know:
- H1, launches an update to its flagship product, HCP Universe, the daily resource for global medical affairs and medical science liaison (MSL) teams.
- New features include a mobile app, Next-gen Smart Search capabilities built on an expansive knowledge graph, out-of-the-box insights tailored to inform MSL and Headquarter decisioning, and AI-powered notifications to improve and accelerate quality HCP engagement.
Establishing AI-Driven Efficient Workflows
H1 is
Read More
Abridge Secures $12.5M to Power AI-Powered Medical Conversations
What You Should Know:
- Abridge, the leader in medical conversation artificial intelligence (AI), today announced an oversubscribed $12.5M Series A-1 led by Wittington Ventures.
- The round also had participation from all existing investors including Union Square Ventures, Bessemer Venture Partners, Pillar Venture Capital, and UPMC Enterprises, and new investors including Turing Award winner Yoshua Bengio, and Whistler Capital.
Automated Solutions to Combat Physician
Read More
Evidence Partners Raises $20M for Automated, Evidence-Based Research
What You Should Know:
- Evidence Partners has announced a growth financing round, their first ever, for $20M, led by Thomvest Ventures.
- With their new AI product DistillerSR, Evidence Partners are changing the way Literature Reviews are conducted, making them efficient, accurate, and less labour-intensive.
AI-Driven Literature Review Software
DistillerSR is a web-based platform that allows researchers to collaborate concurrently on the same projects from anywhere, without
Read More
Digital Front Doors Create Personalized Patient Experience
Heightened patient expectations are changing the way healthcare services are delivered, from the way patients receive care to the way they pay for services and manage their conditions. A need for greater patient-centricity is changing the way payers, providers, and healthcare services organizations do business. The digital front door is an ecosystem of technologies patients use to engage with healthcare, starting from when they detect symptoms, to when they pay or receive post-appointment care.
Read More
